Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.

Simmons C, Khan OF, Brezden-Masley C, Cescon DW, Joy AA, LeVasseur N, Jerzak KJ, Gelmon KA, Sehdev S, Chia S, Webster M, Edwards S, Kumar A, Cao JQ, Boileau JF, Laing K, Bouganim N, Manna M, On Behalf Of Patient Advocacy Breast Cancer Canada.

Open source

DOI: 10.3390/curroncol33050243
Published: 2026-04-24
Container: Curr Oncol
Publisher: Multidisciplinary Digital Publishing Institute
Open access: yes

Credibility signals

uncertain Score 59/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/curroncol33050243,
  title = {Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.},
  author = {Simmons C and  Khan OF and  Brezden-Masley C and  Cescon DW and  Joy AA and  LeVasseur N and  Jerzak KJ and  Gelmon KA and  Sehdev S and  Chia S and  Webster M and  Edwards S and  Kumar A and  Cao JQ and  Boileau JF and  Laing K and  Bouganim N and  Manna M and  On Behalf Of Patient Advocacy Breast Cancer Canada.},
  year = {2026},
  journal = {Curr Oncol},
  doi = {10.3390/curroncol33050243},
  url = {https://doi.org/10.3390/curroncol33050243}
}

RIS

TY  - JOUR
TI  - Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.
AU  - Simmons C
AU  -  Khan OF
AU  -  Brezden-Masley C
AU  -  Cescon DW
AU  -  Joy AA
AU  -  LeVasseur N
AU  -  Jerzak KJ
AU  -  Gelmon KA
AU  -  Sehdev S
AU  -  Chia S
AU  -  Webster M
AU  -  Edwards S
AU  -  Kumar A
AU  -  Cao JQ
AU  -  Boileau JF
AU  -  Laing K
AU  -  Bouganim N
AU  -  Manna M
AU  -  On Behalf Of Patient Advocacy Breast Cancer Canada.
PY  - 2026
JO  - Curr Oncol
DO  - 10.3390/curroncol33050243
UR  - https://doi.org/10.3390/curroncol33050243
ER  -

APA

C, S., OF, K., C, B., DW, C., AA, J., N, L., KJ, J., KA, G., S, S., S, C., M, W., S, E., A, K., JQ, C., JF, B., K, L., N, B., M, M., & Canada., O. B. O. P. A. B. C. (2026). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.. Curr Oncol. https://doi.org/10.3390/curroncol33050243

Source records

europe-pmc · retrieved 2026-09-27T00:18:53.908Z
datacite · retrieved 2026-09-27T00:18:53.893Z
doaj · retrieved 2026-09-27T00:18:53.920Z